SHANGHAI, Nov. 14, 2019 /PRNewswire/ — I-Mab Biopharma (“I-Mab”), a China and U.S.-based clinical-stage biopharmaceutical company exclusively focused on the discovery and development of novel or highly differentiated biologics in immuno-oncology and...
A Phase 2b/3 clinical trial of livoletide, a treatment candidate for excessive eating in people with Prader-Willi syndrome (PWS), has completed recruitment of participants who are 8 to 65 years old. However, enrollment of patients from 4 to 7 years old is still...
There are numerous steps involved in the clinical trial recruitment process, many of which begin prior to the official “start”. From the planning stages to the conclusion of each trial, the work that must be done is nothing short of extensive. Despite the...
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. Rochester, NY, November 14, 2019 –(PR.com)– The Huntington Study Group (HSG), a world leader in...
VBI Vaccines (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, and Brii Biosciences (“Brii Bio”), a clinical-stage company committed to serving patients’ needs and improving...
Email
Text